Correlation Between Sonnet Biotherapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and SAB Biotherapeutics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and SAB Biotherapeutics.
Diversification Opportunities for Sonnet Biotherapeutics and SAB Biotherapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sonnet and SAB is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Sonnet Biotherapeutics Holdings is 3.39 times less risky than SAB Biotherapeutics. The stock trades about -0.12 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 2.51 in SAB Biotherapeutics on January 14, 2025 and sell it today you would earn a total of 0.09 from holding SAB Biotherapeutics or generate 3.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 61.9% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. SAB Biotherapeutics
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| SAB Biotherapeutics |
Sonnet Biotherapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Sonnet Biotherapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |